Krishna Ella

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data To DCGI By Next Week

The Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age has been completed by Bharat Biotech and is expected to submit the data…

View Post

‘People Criticised Us’: Bharat Biotech Head On Covaxin’s Journey From March 2020

The chairman and managing director Krishna Ella addressed the criticism that the vaccine faced since the trial report was awaited, as Bharat Biotech published their interim efficacy report of phase…

View Post

Spotlight

Covid-19 Vaccine War: Covaxin Maker Bharat Biotech On Adar’s ‘Safe Like Water’ Remark

As India is preparing for a major inoculation campaign to prevent the spread of coronavirus, which has killed more than 150,000 people in the world, a vaccine war has emerged.…

View Post

Latest News

Covid-19 Vaccine: Bharat Biotech Begins Phase 3 Trials Of ‘Covaxin’ In India

Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-3 trials of Covaxin, India’s first indigenous vaccine for Covid-19. The Phase-3 trials, which involve 26,000 volunteers across India,…

View Post

Menu

Krishna Ella

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data To DCGI By Next Week

‘People Criticised Us’: Bharat Biotech Head On Covaxin’s Journey From March 2020

Covid-19 Vaccine War: Covaxin Maker Bharat Biotech On Adar’s ‘Safe Like Water’ Remark

Covid-19 Vaccine: Bharat Biotech Begins Phase 3 Trials Of ‘Covaxin’ In India

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?